Taysha Gene Therapies Inc (TSHA)
2.57
-0.01
(-0.39%)
USD |
NASDAQ |
May 03, 16:00
2.575
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Total Assets (Quarterly): 172.73M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 172.73M |
| September 30, 2023 | 195.77M |
| June 30, 2023 | 81.54M |
| March 31, 2023 | 101.60M |
| December 31, 2022 | 126.28M |
| September 30, 2022 | 111.47M |
| June 30, 2022 | 142.33M |
| March 31, 2022 | 165.98M |
| Date | Value |
|---|---|
| December 31, 2021 | 213.96M |
| September 30, 2021 | 241.04M |
| June 30, 2021 | 241.86M |
| March 31, 2021 | 242.83M |
| December 31, 2020 | 258.88M |
| September 30, 2020 | 279.27M |
| June 30, 2020 | 11.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.32M
Minimum
Jun 2020
279.27M
Maximum
Sep 2020
172.46M
Average
172.73M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 57.42M |
| Lifecore Biomedical Inc | 255.15M |
| Relmada Therapeutics Inc | 97.55M |
| ACADIA Pharmaceuticals Inc | 748.96M |
| Cyclacel Pharmaceuticals Inc | 8.805M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 97.79M |
| Shareholders Equity (Quarterly) | 74.94M |
| Debt to Equity Ratio | 0.5406 |
| Current Ratio | 4.077 |
| Net Debt Paydown Yield | -0.14% |